Icahn School of Medicine at Mount Sinai

 

Insights from 2023 ASH Annual Meeting
D

ASH 2023 Insights: "Outcomes After CAR-T in MM Patients With Extramedullary and Paramedullary Disease"

By Insights from 2023 ASH Annual Meeting FEATURING Darren Pan
By Insights from 2023 ASH Annual Meeting FEATURING Darren Pan
52 views
December 22, 2023
Comments 0
Login to view comments. Click here to Login
Videos
48:17

New

Pulmonary Hypertension: The Future Is Now

Icahn School of Medicine at Mount Sinai

H. Poor

8 views
57:16

New

Classification, Diagnosis and Management of Pulmonary Hypertension: …

Icahn School of Medicine at Mount Sinai

R. Benza

38 views
53:57

New

Obstructive Sleep Apnea - Overview and Management

Icahn School of Medicine at Mount Sinai

J. Wang

14 views
16:17

New

CAR-T in MM: Best Practices in Patient Selection, Treatment, and Mul…

Icahn School of Medicine at Mount Sinai

A. Rossi

48 views
04:39

ESMO 2024 Insights: TACE ± Lenvatinib + Pembro for Int-Stage HCC - P…

2024 ESMO Annual Meeting Insights Hub

J. Llovet

196 views
16:56

ASCO® 2024 Insights: "Sequencing Immunotherapy for Myeloma"

2024 ASCO® Annual Meeting Insights Hub

S. Parekh

243 views
05:26

ASCO® 2024 Insights: "Indirect Comparison of Linvoseltamab Vs. Tecli…

2024 ASCO® Annual Meeting Insights Hub

S. Jagannath

182 views
16:52

Navigating aGVHD Treatment: Integrating Recent Updates in Clinical M…

Icahn School of Medicine at Mount Sinai

J. Ferrara

47 views
11:32

Leveraging Liquid Biopsy in Lung Cancer

Icahn School of Medicine at Mount Sinai

C. Rolfo

102 views
16:31

PanRAF Inhibitors in NSCLC

Icahn School of Medicine at Mount Sinai

R. Veluswamy

16 views
15:16

AACR 2024 Insights: "Linvoseltamab, a BCMA-Targeted BsAb, in Pts Wit…

Icahn School of Medicine at Mount Sinai

S. Jagannath

64 views
21:52

ASH 2023 Summary: "MF, ET, and PV - Highlights and Clinical Implicat…

Insights from 2023 ASH Annual Meeting

D. Tremblay

402 views
10:06

ASH 2023 Insights: "Outcomes After CAR-T in MM Patients With Extrame…

Insights from 2023 ASH Annual Meeting

D. Pan

52 views
06:14

Multiple Myeloma: Inflammatory Biomarkers and Outcomes CAR T-Cell Th…

Insights from 2023 ASH Annual Meeting

D. Pan

72 views
03:14

ASH 2023 Insights: "MyDRUG Sub-Protocol Y3 Results - Selinexor, Ixaz…

Insights from 2023 ASH Annual Meeting

J. Richter

126 views
06:51

Prevalence and Prediction of Ruxolitinib Treatment Emergent Thromboc…

Insights from 2023 ASH Annual Meeting

D. Tremblay

432 views
10:38

ASH 2023 Insights: "Venetoclax Improves Response Rates But Not Survi…

Insights from 2023 ASH Annual Meeting

D. Tremblay

35 views
03:17

IMS 2023 Insights: "Highlights From the International Myeloma Societ…

Insights from 2023 IMS Annual Meeting

J. Richter

354 views
15:14

Safety Profile of Ruxolitinib in Patients With MF

Icahn School of Medicine at Mount Sinai

D. Tremblay

857 views
44:42

Managing the Nonreproductive Comorbidities of Polycycstic Ovary Synd…

Icahn School of Medicine at Mount Sinai

A. Dunaif

765 views
04:34

Revisiting the Role of Alkylating Agents in Myeloma: Up-to-Date Evid…

Icahn School of Medicine at Mount Sinai

J. Richter

184 views
24:39

Multiple Myeloma: Adverse Effects of CAR-T

Icahn School of Medicine at Mount Sinai

S. Rajeeve

332 views
33:05

Leveraging SCLC Subtypes and Other Biomarkers

Icahn School of Medicine at Mount Sinai

F. Hirsch

281 views
52:39

Myeloma in 2023: So Many Drugs, Yet So Few Cures

Yale Cancer Center

A. Chari

525 views
10:46

Overview of JAKARTA & JAKARTA2 Trials: Impact of Fedratinib on Splee…

Icahn School of Medicine at Mount Sinai

J. Waksal

271 views
09:47

What's the Difference? Covalent vs. Non-Covalent BTKis in MCL

Icahn School of Medicine at Mount Sinai

J. Brody

59 views
15:31

Myelofibrosis Treatment Options Beyond the JAK/STAT Pathway

Icahn School of Medicine at Mount Sinai

M. Kremyanskaya

824 views
23:07

Kidney Week 2022: Cell-to-Cell Chats in the Diabetic Kidney Endothel…

Icahn School of Medicine at Mount Sinai

I. Daehn

102 views
12:43

Outcomes of MM Pts Progressing After BCMA-Targeted CAR T-Cell Therapy

Oliver Van Oekelen

80 views
14:03

ASH 2022 Neurotoxicity With Motor Symptoms After BCMA-Directed CAR-T…

ASH 2022 Conference Coverage

S. Parekh

74 views
09:13

SABCS 2022 Predictors of Response to Neoadjuvant Chemo in Breast Can…

SABCS 2022 Conference Coverage

N. Bilani

531 views
05:07

TKI in the Management of Advanced HCC

Icahn School of Medicine at Mount Sinai

A. Villanueva

233 views
11:42

Symptom Assessments in Myelofibrosis and How to Examine the Spleen

Icahn School of Medicine at Mount Sinai

M. Kremyanskaya

73 views
25:49

Triplet Regimens in Early Relapse MM: Evolving Treatment Dynamics

Icahn School of Medicine at Mount Sinai

C. Rodriguez

126 views